Growth Metrics

Biofrontera (BFRI) Non-Current Receivables (2021 - 2022)

Biofrontera has reported Non-Current Receivables over the past 2 years, most recently at $2.8 million for Q4 2022.

  • For Q4 2022, Non-Current Receivables changed 0.0% year-over-year to $2.8 million; the TTM value through Dec 2022 reached $2.8 million, changed 0.0%, while the annual FY2022 figure was $2.8 million, 0.0% changed from the prior year.
  • Non-Current Receivables for Q4 2022 was $2.8 million at Biofrontera, roughly flat from $2.8 million in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $2.8 million in Q4 2021 and troughed at $2.8 million in Q4 2021.